JW Pharmaceutical: Major management decision

August 28, 2026 · KOSPI · Market cap ₩625.2bn · JW Pharmaceutical chart & price →
AI reading
★★★ Bullish · Material event

Application for Phase 3 clinical trial approval for diabetes treatment

Key figures: 임상시험 기간 2027.01~2029.02

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

Other filings by JW Pharmaceutical
All of today's important filings (Filings Radar) →

For information only. Not investment advice.